MQSA Insights

<!– –> <!– Page Last Updated: 03/11/2016 –> Page Last Updated: 03/11/2016 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Public Workshop – Mass Spectrometry in the Clinic: Regulatory Considerations Surrounding Validation of Liquid Chromatography

The Food and Drug Administration (FDA) is announcing a public workshop entitled “Mass Spectrometry in the Clinic: Regulatory Considerations Surrounding Validation of Liquid Chromatography-Mass Spectrometry Based Devices.” The topics to be discussed are the specific analytical and clinical study designs and considerations for validation and use of liquid chromatography/mass-spectrometry (LC/MS)-based in vitro diagnostic devices (IVDs)…

Warning about magnetic interference between breast tissue expanders with magnetic ports and implantable cardioverter-defibrillators (ICDs) or pacemakers – Letter to Health Care Providers

March 8, 2016 Dear Breast Surgeons, Cardiac Electrophysiologists, Cardiologists, and Plastic Surgeons: The FDA is aware of reports of magnetic interference between breast tissue expanders with magnetic injection ports and either implantable cardioverter-defibrillators (ICDs) or pacemakers in patients, interfering with the functioning of these cardiac devices. The FDA analyzed peer-reviewed literature, device labeling, adverse event…